AIDS remains an incurable disease. In the world, HIV/AIDS has resulted in estimated 40 million deaths while 36.9 million...
Aptose Biosciences Inc., a clinical-stage biotechnology company committed to developing personalized therapies addressin...
Parkinson’s disease is one of the leading neural degenerative disorders which is primarily caused by death of dopa...
Yaoshibang, a Guangzhou-based online pharmacy trading and education platform, recently completed a RMB420 million ($65.7...
Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., launched the Shanghai Lung ...
Suven Life Sciences said it has obtained one product patent each from China and the US related to its 5-HT4 and 5 ...
Ascletis (partner of WuXi STA) receives approval from National Drug Administration of China (CNDA, former CFDA) of its C...
Hebron Technology Co., Ltd., a developer, manufacturer and installer of valves and pipe fittings for use in the pharmace...
Shanghai Kinetic Medical Co recently announced that it plans to take over US medical technology company Elliquence LLC f...
Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of d...
Zai Lab, a Shanghai-based innovative biopharmaceutical company, recently announced that Mr William Liang has b...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
GE Healthcare will provide China-based Xiangxue Pharmaceutical (XPH) with a FlexFactory for cell therapy. The system, ex...
Oncologie, an innovative biopharmaceutical company, recently announced that it is launching operations in both Boston an...
A group of researchers from Chinese Academy of Sciences and Peking University Third Hospital has developed a new type of...
China has approved the first domestically developed, long-acting injectable HIV drug Albuvirtide, which could be a boon ...
Singapore- Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorder...
Ally Bridge Group (ABG), a China-centered healthcare investor, has completed a Series A investment, as the first part of...
